Evonik has bought one of its existing portfolio companies, Friedrich Schiller University Jena spinout JeNaCell, for an undisclosed sum.

Imec.xpand has returned for a $16m series B round that will allow Spectricity to accelerate the development of its sensors and imagers.

University of Oxford’s genetic therapeutics spinout has secured the crossover funding eight months after a series A round also backed by OSI.

Main Sequence Ventures has contributed to a $53.3m series B-plus for V2Food, having already backed the initial $55m series B round last October.

Osage University Partners has backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

UC Berkeley’s robotics software developer Covariant hiked its overall funding to $147m in a round led by returning investor Index Ventures.

MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

4490 Ventures-backed Rentable has received $22.5m in its series B round.

MIT spinout Quaise has added $12m to its coffers, having previously collected seed funding from The Engine.

A range of strategic investors have backed a series A5 round for the clean nuclear energy technology developer that leverages OSU research.